Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
ClinicalTrials.gov study NCT03265496. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy
ClinicalTrials.gov study NCT04508829. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC
ClinicalTrials.gov study NCT02847377. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers
ClinicalTrials.gov study NCT05099549. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial
ClinicalTrials.gov study NCT03426371. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy
ClinicalTrials.gov study NCT02906163. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Idylla EGFR Lung Trial
ClinicalTrials.gov study NCT04962191. IPD Sharing: NO. Countries: 1. Publications: 0.
Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03766490. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients
ClinicalTrials.gov study NCT05463224. IPD Sharing: NO. Countries: 1. Publications: 0.
Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR)
ClinicalTrials.gov study NCT03151161. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Lung Cancer
ClinicalTrials.gov study NCT05517083. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identification of EGFR-TKIs Sensitivity or Resistance Markers in NSCLC May Help in Optimal Patient Selection
ClinicalTrials.gov study NCT00831454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Whole Genomic Landscape of Advanced EGFR-mutant NSCLC
ClinicalTrials.gov study NCT03969823. IPD Sharing: NO. Countries: 1. Publications: 0.
Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer
ClinicalTrials.gov study NCT00243854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
ClinicalTrials.gov study NCT00063401. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of the Combination of Anlotinib and JS001 in EGFR-TKI Resistant T790M-Negative NSCLC
ClinicalTrials.gov study NCT04116918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma
ClinicalTrials.gov study NCT02146118. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation
ClinicalTrials.gov study NCT02001896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Furmonertinib in Patients With Leptomeningeal Metastases Associated With EGFR Mutated NSCLC
ClinicalTrials.gov study NCT05813522. IPD Sharing: NO. Countries: 1. Publications: 0.
Lazertinib+Pemetrexed/Carboplatin in Patients With EGFR Sensitizing Mutation Positive Recurrent or Metastatic Non-Small Cell Lung Cancer Failed to Prior Lazertinib
ClinicalTrials.gov study NCT05786430. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.